340B Drug Pricing Program
Press Release
Statement on Final CY 2018 OPPS Rule
Contact: Colin Milligan, 202-638-5491, cmilligan@aha.org
Marie Johnson, 202-626-2351, mjohnson@aha.org
Tom Nickels
Executive Vice President
American Hospital Association
November 1, 2017
The Health Resources and Services Administration has announced that 340B Drug Pricing Program hospitals in areas affected by recent natural disasters can immediately enroll in the program instead of waiting for the normal registration period. “HRSA recognizes that circumstances surrounding disaster…
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care…
The latest report from a group financed and backed by the pharmaceutical industry “continues to misrepresent” the 340B Drug Pricing Program and its “successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and…
The latest report from AIR340B, a group financed and backed by the pharmaceutical industry, continues to misrepresent a program with a successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and comprehensive…
Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services (CMS) to “carefully consider stakeholder feedback” before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. “The long-term success of the…
Fifty-seven senators Friday urged the Centers for Medicare & Medicaid Services to “carefully consider stakeholder feedback" before the agency finalizes its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program. "The long-term success of the 340B…
The 340B Drug Pricing Program “has enabled hospitals and health systems to support and expand access and services consistent with their mission and the program’s original and ongoing charge,” the AHA and Association of American Medical Colleges today told leaders of the House Energy and Commerce…
Two hundred twenty-eight members of the House of Representatives yesterday urged the Centers for Medicare & Medicaid Services to abandon its proposal to reduce Medicare Part B payment for drugs acquired through the 340B Drug Pricing Program.